Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$1.15 - $6.45 $251,964 - $1.41 Million
-219,100 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.22 - $6.33 $606,648 - $1.19 Million
188,400 Added 613.68%
219,100 $1.35 Million
Q2 2018

Aug 14, 2018

SELL
$5.39 - $8.96 $70,070 - $116,480
-13,000 Reduced 29.75%
30,700 $196,000
Q1 2018

May 15, 2018

BUY
$6.69 - $17.96 $179,292 - $481,328
26,800 Added 158.58%
43,700 $305,000
Q4 2017

Feb 14, 2018

BUY
$10.87 - $13.9 $92,395 - $118,150
8,500 Added 101.19%
16,900 $213,000
Q3 2017

Nov 14, 2017

BUY
$11.86 - $17.34 $99,624 - $145,656
8,400
8,400 $100,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.